Adams et al., 2006 - Google Patents
Empfehlungen zur Diagnostik und Therapie der Schockformen der IAG Schock der DIVI: Teil 7: Besonderheiten im KindesalterAdams et al., 2006
- Document ID
- 18145035501439872686
- Author
- Adams H
- Baumann G
- Cascorbi I
- Ebener C
- Emmel M
- Geiger S
- Janssens U
- Klima U
- Klippe H
- Knoefel W
- Marx G
- Müller-Werdan U
- Pape H
- Piek J
- Prange H
- Roesner D
- Roth B
- Schürholz T
- Standl T
- Teske W
- Vogt P
- Werner G
- Windolf J
- Zander R
- Zerkowski H
- Publication year
- Publication venue
- Intensivmedizin und Notfallmedizin
External Links
Snippet
Kinder sollen nach Primärversorgung und initialer Stabilisierung in ein Zentrum verlegt werden, das auf die Versorgung von Patienten der jeweiligen Altersgruppe spezialisiert ist. Mit dem entsprechenden Zentrum ist möglichst frühzeitig Kontakt aufzunehmen, um den …
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/06—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins
- A61K47/08—Organic compounds, e.g. mineral oil, petrolatum, synthetic polyolefins containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES, AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0457—Semi-solid forms, ointments, gels, hydrogels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69426879T2 (en) | PLASMA-LIKE SOLUTION | |
Collins | Massive blood transfusion | |
Adams et al. | Empfehlungen zur Diagnostik und Therapie der Schockformen der IAG Schock der DIVI: Teil 7: Besonderheiten im Kindesalter | |
Wright et al. | Measurement of maximal permissible cerebral ischemia and a study of its pharmacologic prolongation | |
DE602004002585T2 (en) | Lactate-containing pharmaceutical composition and its uses | |
KR19990022355A (en) | Blood dilution facilitated by monitoring of oxygenation status | |
DE4439480C1 (en) | Use of D, L-alpha-lipoic acid and / or its enantiomers, and / or their derivatives as an additive in red cell liquid preserves for homologous and autologous erythrocyte concentrates and as an additive in erythrocyte cryoconserves for homologous and autologous erythrocyte concentrates | |
Lichtenberger | Transfusion medicine in exotic pets | |
Binger et al. | Experimental studies on rapid breathing: I. Tachypnea, independent of anoxemia, resulting from multiple emboli in the pulmonary arterioles and capillaries | |
US20150093368A1 (en) | Methods for enhancing oxygenation of jeopardized tissue | |
Coran et al. | The effect of crystalloid resuscitation in hemorrhagic shock on acid-base balance: A comparison between normal saline and Ringer's lactate solutions | |
Pallis | ABC of brain stem death. Diagnosis of brain stem death--II. | |
Malm et al. | The effect of acidosis on sympatho-adrenal stimulation: particular reference to cardiopulmonary bypass | |
Barrett et al. | Increased pulmonary arteriovenous shunting in humans following blood transfusion: relation to screen filtration pressure of transfused blood and prevention by dacron wool (Swank) filtration | |
Trede et al. | Pathophysiologic aspects of profound hypothermia with extracorporeal circulation | |
Opdyke et al. | Splenic responses to stimulation in Squalus acanthias | |
Tateishi et al. | Nimodipine does not improve neurologic outcome after 14 minutes of cardiac arrest in cats. | |
Harrison et al. | THE REGULATION OF CIRCULATION: VIII. The Relative Importance of Nervous, Endocrine and Vascular Regulation in the Response of the Cardiac Output to Anoxemia | |
TALMAGE et al. | Total blood washout for Reye's syndrome | |
EP1682167B1 (en) | Use of hyperpolymer haemoglobin for treating a pulmonary oedema | |
Simpson et al. | Some physiological and metabolic effects of sodium nitroprusside and cyanide in the dog | |
Tsukamoto et al. | Fatal hyperkalemia due to rapid red cell transfusion in a critically ill patient | |
Vazeery et al. | CHANGES IN CARDIAC OUTPUT AND SYSTEMIC ARTERIAL PRESSURE AFTER INSERTION OF ACRYLIC CEMENT DURING TRIMETAPHAN, SODIUM NITROPRUSSIDE AND GLYCEROL TRINITRATE-INDUCED HYPOTENSION: A comparison with changes during normotension | |
Bargeron et al. | The importance of an adequate circulating blood volume following superior vena cava—right pulmonary artery anastomosis | |
Featherstone et al. | The introduction of synthetic colloids |